+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Over the Counter (OTC) Drugs - Global Strategic Business Report

  • PDF Icon

    Report

  • 194 Pages
  • April 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5309780
The global market for Over the Counter (OTC) Drugs is estimated at US$168.5 Billion in 2023 and is projected to reach US$249.8 Billion by 2030, growing at a CAGR of 5.8% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Cough, Cold & Flu Drugs segment, which is expected to reach US$63.7 Billion by 2030 with a CAGR of a 6.8%. The Analgesics segment is also set to grow at 6.5% CAGR over the next 7 years.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $45 Billion in 2023, and China, forecasted to grow at an impressive 9.4% CAGR to reach $56.8 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Over the Counter (OTC) Drugs Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Over the Counter (OTC) Drugs Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Over the Counter (OTC) Drugs Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Bayer AG, Boehringer Ingelheim International GmbH, GlaxoSmithKline PLC, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 42 Featured):

  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Novartis AG
  • Pfizer, Inc.
  • Sanofi SA
  • Takeda Pharmaceutical Co., Ltd.

MarketGlass Platform

Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Over the Counter (OTC) Drugs - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Global Economic Update
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Over the Counter (OTC) Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 2: World Historic Review for Over the Counter (OTC) Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 3: World 16-Year Perspective for Over the Counter (OTC) Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Cough, Cold & Flu by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 5: World Historic Review for Cough, Cold & Flu by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 6: World 16-Year Perspective for Cough, Cold & Flu by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Analgesics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 8: World Historic Review for Analgesics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 9: World 16-Year Perspective for Analgesics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Dermatology Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 11: World Historic Review for Dermatology Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 12: World 16-Year Perspective for Dermatology Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Gastrointestinal Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 14: World Historic Review for Gastrointestinal Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 15: World 16-Year Perspective for Gastrointestinal Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Minerals & Vitamins Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 17: World Historic Review for Minerals & Vitamins Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 18: World 16-Year Perspective for Minerals & Vitamins Supplements by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Other Categories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 20: World Historic Review for Other Categories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 21: World 16-Year Perspective for Other Categories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 22: World Over the Counter (OTC) Drugs Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Over the Counter (OTC) Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 23: USA Recent Past, Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Minerals & Vitamins Supplements, Gastrointestinal Products, Dermatology Products and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 24: USA Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Minerals & Vitamins Supplements, Gastrointestinal Products, Dermatology Products and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 25: USA 16-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Minerals & Vitamins Supplements, Gastrointestinal Products, Dermatology Products and Other Categories for the Years 2014, 2024 & 2030
CANADA
  • Table 26: Canada Recent Past, Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Minerals & Vitamins Supplements, Gastrointestinal Products, Dermatology Products and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 27: Canada Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Minerals & Vitamins Supplements, Gastrointestinal Products, Dermatology Products and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 28: Canada 16-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Minerals & Vitamins Supplements, Gastrointestinal Products, Dermatology Products and Other Categories for the Years 2014, 2024 & 2030
JAPAN
  • Over the Counter (OTC) Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 29: Japan Recent Past, Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Minerals & Vitamins Supplements, Gastrointestinal Products, Dermatology Products and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 30: Japan Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Minerals & Vitamins Supplements, Gastrointestinal Products, Dermatology Products and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 31: Japan 16-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Minerals & Vitamins Supplements, Gastrointestinal Products, Dermatology Products and Other Categories for the Years 2014, 2024 & 2030
CHINA
  • Over the Counter (OTC) Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 32: China Recent Past, Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Minerals & Vitamins Supplements, Gastrointestinal Products, Dermatology Products and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 33: China Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Minerals & Vitamins Supplements, Gastrointestinal Products, Dermatology Products and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 34: China 16-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Minerals & Vitamins Supplements, Gastrointestinal Products, Dermatology Products and Other Categories for the Years 2014, 2024 & 2030
EUROPE
  • Over the Counter (OTC) Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 35: Europe Recent Past, Current & Future Analysis for Over the Counter (OTC) Drugs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 36: Europe Historic Review for Over the Counter (OTC) Drugs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 37: Europe 16-Year Perspective for Over the Counter (OTC) Drugs by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • Table 38: Europe Recent Past, Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Minerals & Vitamins Supplements, Gastrointestinal Products, Dermatology Products and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 39: Europe Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Minerals & Vitamins Supplements, Gastrointestinal Products, Dermatology Products and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 40: Europe 16-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Minerals & Vitamins Supplements, Gastrointestinal Products, Dermatology Products and Other Categories for the Years 2014, 2024 & 2030
FRANCE
  • Over the Counter (OTC) Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 41: France Recent Past, Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Minerals & Vitamins Supplements, Gastrointestinal Products, Dermatology Products and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 42: France Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Minerals & Vitamins Supplements, Gastrointestinal Products, Dermatology Products and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 43: France 16-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Minerals & Vitamins Supplements, Gastrointestinal Products, Dermatology Products and Other Categories for the Years 2014, 2024 & 2030
GERMANY
  • Over the Counter (OTC) Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 44: Germany Recent Past, Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Minerals & Vitamins Supplements, Gastrointestinal Products, Dermatology Products and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 45: Germany Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Minerals & Vitamins Supplements, Gastrointestinal Products, Dermatology Products and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 46: Germany 16-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Minerals & Vitamins Supplements, Gastrointestinal Products, Dermatology Products and Other Categories for the Years 2014, 2024 & 2030
ITALY
  • Table 47: Italy Recent Past, Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Minerals & Vitamins Supplements, Gastrointestinal Products, Dermatology Products and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 48: Italy Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Minerals & Vitamins Supplements, Gastrointestinal Products, Dermatology Products and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 49: Italy 16-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Minerals & Vitamins Supplements, Gastrointestinal Products, Dermatology Products and Other Categories for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Over the Counter (OTC) Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 50: UK Recent Past, Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Minerals & Vitamins Supplements, Gastrointestinal Products, Dermatology Products and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 51: UK Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Minerals & Vitamins Supplements, Gastrointestinal Products, Dermatology Products and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 52: UK 16-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Minerals & Vitamins Supplements, Gastrointestinal Products, Dermatology Products and Other Categories for the Years 2014, 2024 & 2030
SPAIN
  • Table 53: Spain Recent Past, Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Minerals & Vitamins Supplements, Gastrointestinal Products, Dermatology Products and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 54: Spain Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Minerals & Vitamins Supplements, Gastrointestinal Products, Dermatology Products and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 55: Spain 16-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Minerals & Vitamins Supplements, Gastrointestinal Products, Dermatology Products and Other Categories for the Years 2014, 2024 & 2030
RUSSIA
  • Table 56: Russia Recent Past, Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Minerals & Vitamins Supplements, Gastrointestinal Products, Dermatology Products and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 57: Russia Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Minerals & Vitamins Supplements, Gastrointestinal Products, Dermatology Products and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 58: Russia 16-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Minerals & Vitamins Supplements, Gastrointestinal Products, Dermatology Products and Other Categories for the Years 2014, 2024 & 2030
REST OF EUROPE
  • Table 59: Rest of Europe Recent Past, Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Minerals & Vitamins Supplements, Gastrointestinal Products, Dermatology Products and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 60: Rest of Europe Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Minerals & Vitamins Supplements, Gastrointestinal Products, Dermatology Products and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 61: Rest of Europe 16-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Minerals & Vitamins Supplements, Gastrointestinal Products, Dermatology Products and Other Categories for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Over the Counter (OTC) Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 62: Asia-Pacific Recent Past, Current & Future Analysis for Over the Counter (OTC) Drugs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 63: Asia-Pacific Historic Review for Over the Counter (OTC) Drugs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 64: Asia-Pacific 16-Year Perspective for Over the Counter (OTC) Drugs by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • Table 65: Asia-Pacific Recent Past, Current & Future Analysis for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Minerals & Vitamins Supplements, Gastrointestinal Products, Dermatology Products and Other Categories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 66: Asia-Pacific Historic Review for Over the Counter (OTC) Drugs by Category - Cough, Cold & Flu, Analgesics, Minerals & Vitamins Supplements, Gastrointestinal Products, Dermatology Products and Other Categories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 67: Asia-Pacific 16-Year Perspective for Over the Counter (OTC) Drugs by Category - Percentage Breakdown of Value Sales for Cough, Cold & Flu, Analgesics, Minerals & Vitamins Supplements, Gastrointestinal Products, Dermatology Products and Other Categories for the Years 2014, 2024 & 2030
AUSTRALIA
  • Over the Counter (OTC) Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
INDIA
  • Over the Counter (OTC) Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Over the Counter (OTC) Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Over the Counter (OTC) Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Over the Counter (OTC) Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Novartis AG
  • Pfizer, Inc.
  • Sanofi SA
  • Takeda Pharmaceutical Co., Ltd.

Table Information